05 Compliance

The regulatory file for trypsin

Technical document 05 · Reviewed 2026-11-19 · Trypsin

On this page
  1. What the file contains
  2. European Union
  3. United States
  4. Contaminants and limits
  5. Claims and the label
  6. Documents in the file
  7. Checklist before the first order

Trypsin is an enzyme preparation obtained from pancreas, and its regulatory file is built around three things: the source, the specification and the market. The source decides the species and the TSE statement, the specification decides the activity and the contaminant panel, and the market decides the route and the label. The buyer's regulatory team confirms that route for the destination; this page lists the frameworks and the documents the file will need.

In one line

The specification describes the powder; the regulatory file has to name the source species, the TSE statement and the route for the destination.

What the file contains

A usable file answers four questions, in this order. Which material is being bought, and at which specification revision? Which lot is on the dock, and what did its certificate measure? Which limits and which label rules does the destination apply to the finished product? What happens to the file if the source, the carrier or the granulation changes? The lot certificate covers the second question, the technical data sheet the first, and the safety data sheet the handling in the warehouse. The route question is answered by none of the three.

Three statements are specific to an animal-derived enzyme and belong in every file: the species and tissue of origin, a TSE statement for the pancreas material, and a statement on the carrier. The carrier matters because a lactose carrier brings a milk allergen with it, and the allergen statement should name the carrier rather than the enzyme alone.

European Union

Regulation (EC) No 1332/2008 is the framework for food enzymes, including enzymes used as processing aids, and it provides that a food enzyme must be on the EU list before it is placed on the market. The list is being established in parts, and the European Food Safety Authority has published safety evaluations of trypsin preparations, including one from porcine pancreas. Whether a particular preparation and use are covered is confirmed by the buyer's regulatory team; check the current text and the current list before relying on either.

Two further instruments sit beside it. Regulation (EC) No 999/2001 governs transmissible spongiform encephalopathy risk for animal material; pancreas is not on the specified-risk-material list, but the regulation still applies to the source and the process, and the file needs the species, the tissue and the source-country statement. Regulation (EU) No 1169/2011 governs labelling: an enzyme used as a processing aid that performs no technological function in the final food is not declared, while an enzyme that is an ingredient of a supplement is. The label route for a supplement is a member-state question as well, and it is checked for the destination.

United States

Title 21 of the Code of Federal Regulations, section 184.1914, affirms trypsin — an enzyme preparation obtained from purified extracts of porcine or bovine pancreas — as generally recognized as safe for direct addition to food under current good manufacturing practice. That affirmation is a food-use basis. Whether it covers a particular supplement, and which preparation, is a question for the buyer's regulatory team, and the current text of the section should be read rather than a summary.

For a dietary supplement, the ingredient is declared under the framework that applies to dietary ingredients. A new dietary ingredient question turns on the marketing history of the ingredient before 15 October 1994, and the buyer's regulatory team documents that history with the supplier's support. The label panel, the other-ingredient list and the claim wording are reviewed separately from the certificate.

Contaminants and limits

The catalog limits are release gates for the powder. The file also has to show the finished-product calculation, because a limit that is comfortable per kilogram of powder can be tight once the daily dose is taken into account.

Catalog limits and what the finished-product file should show
ParameterCatalog limitWhat the file should show
Lead (Pb)≤3 mg/kgLot result, method and the calculation at the daily dose
Arsenic (As)≤2 mg/kgLot result and the limit agreed for the market
Cadmium (Cd)≤1 mg/kgLot result and any category exception
Mercury (Hg)≤0.1 mg/kgLot result and method
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentThe count, the absence statement and the test method
Loss on drying≤5.0%The measured figure, since water dilutes the activity per gram

Claims and the label

No disease-related claim belongs on a product that contains trypsin, and the enzyme's activity is not a clinical effect. A structure or function wording is reviewed by the brand's regulatory reviewer for the market, the form and the finished product, and that review is separate from the certificate. The certificate reports what the lot measures; it does not approve a sentence on a label.

Two wording habits cause trouble. One is to describe the enzyme by what it digests rather than by what it is, which slides towards a physiological claim. The other is to use “protease” on the panel when the ingredient is trypsin, which hides the identity the specification has just established. Name the enzyme and its source, and keep the claim with the reviewer.

Documents in the file

Documents to request with the first lot
DocumentWhat it establishesAsk for it when
SpecificationThe version, the activity, the method and the limitsBefore the quotation is accepted
COAThe results for one lotWith every lot
Technical data sheetForm, solubility, storage and packAt qualification
Safety data sheetDust, sensitisation and handling controlsAt qualification, and for the warehouse
Species and TSE statementThe animal source and the BSE/TSE positionBefore the first shipment
Allergen and carrier statementWhat the carrier is and what it may carryBefore the label is written
GMO and origin statementThe process and the manufacturing siteAt qualification
Residual solvent statementWhat was used in the purificationWhere the market requires it

Checklist before the first order

  • The specification names trypsin, the species of origin, the CAS number and the activity method.
  • The COA, the TDS and the SDS are on file with version numbers.
  • The TSE statement, the allergen statement and the carrier are confirmed.
  • The contaminant results have been converted to the daily dose of the finished product.
  • The label wording and the claim have had a review for the destination market.
  • Change control covers the source, the carrier and any granulation step.

The catalog entry is on the trypsin product page; the COA page explains the lot certificate, the identity page covers the analytical evidence, and the EU and US notes summarise the frameworks. The quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation